Penicillin

The discovery of penicillin is attributed to Scottish physician and microbiologist Alexander Fleming at St. Mary's Hospital in London in 1928. Returning from holiday, Fleming noticed that a mold, later identified as Penicillium notatum, had contaminated a Petri dish of Staphylococcus bacteria and had killed the bacteria around it.¹ He published his findings in 1929, but the instability of the compound and the difficulty of large-scale production hindered further development.

It was not until the early 1940s that a team at the University of Oxford, led by Howard Florey and Ernst Boris Chain, succeeded in purifying and mass-producing penicillin, using a more productive mold strain, Penicillium chrysogenum. Their work, supported by the US government, enabled the first clinical trials and widespread use during World War II.

Penicillins are beta-lactam antibiotics that inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis. They are bactericidal and effective against many Gram-positive bacteria, including streptococci, staphylococci (except resistant strains), and some Gram-negative cocci.²

There are several classes of penicillins: natural penicillins (e.g., penicillin G and V), penicillinase-resistant penicillins (e.g., methicillin, oxacillin), aminopenicillins (e.g., ampicillin, amoxicillin), and extended-spectrum penicillins (e.g., piperacillin). These vary in spectrum, acid stability, and resistance to beta-lactamases.³

Penicillin G is used to treat infections such as strep throat, syphilis, and bacterial endocarditis. Penicillin V is given orally for minor infections. Aminopenicillins are broader-spectrum and used for respiratory and urinary tract infections. However, widespread use has led to the emergence of resistant bacteria, notably Staphylococcus aureus producing beta-lactamase, which inactivates penicillin. This prompted the development of beta-lactamase inhibitors like clavulanic acid, combined with amoxicillin (Augmentin).⁴

Penicillin remains the drug of choice for many infections, but resistance is a growing concern, necessitating judicious use and development of new antibiotics.

Penicillin is generally well-tolerated, but allergic reactions occur in about 10% of patients, ranging from mild rashes to life-threatening anaphylaxis. Interestingly, many patients labeled as penicillin-allergic are not truly allergic; studies show that over 90% of such patients can tolerate penicillin after formal allergy testing.⁵ This has led to antibiotic stewardship programs to de-label patients and use more appropriate antibiotics.

Other adverse effects include gastrointestinal upset, and rarely, neurotoxicity at high doses in renal failure.

Beyond the well-known story, several lesser-known facts enrich the history of penicillin:

• Mary Hunt, a lab assistant in Peoria, Illinois, discovered a moldy cantaloupe in a market that yielded the high-producing Penicillium chrysogenum strain used for mass production.⁶
• Early clinical use: The first patient treated in the US was Anne Miller in 1942, who recovered from a streptococcal infection after penicillin was flown in from Merck.
• Penicillin in agriculture: It is used as a growth promoter in livestock feed, though this practice is controversial due to antibiotic resistance.
• Chemical structure: The beta-lactam ring is essential for activity; its discovery led to the development of other beta-lactam antibiotics like cephalosporins.
• Penicillin and the Nobel Prize: Fleming, Florey, and Chain shared the 1945 Nobel Prize in Physiology or Medicine, but the contribution of Norman Heatley, who developed the extraction method, was overlooked.

Beta-lactam

A class of antibiotics containing a beta-lactam ring, including penicillins, cephalosporins, and carbapenems.

Penicillin-binding proteins (PBPs)

Enzymes involved in bacterial cell wall synthesis that are the targets of penicillin.

Anaphylaxis

A severe, potentially life-threatening allergic reaction.

Antibiotic stewardship

Coordinated efforts to improve antibiotic use to combat resistance.